Cargando…
High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique
BACKGROUND: Few countries in sub-Saharan Africa know the magnitude of their HIV epidemic among people who inject drugs (PWID). This was the first study in Mozambique to measure prevalence of HIV, HBV, and HCV, and to assess demographic characteristics and risk behaviors in this key population. METHO...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889180/ https://www.ncbi.nlm.nih.gov/pubmed/31791273 http://dx.doi.org/10.1186/s12879-019-4655-2 |
_version_ | 1783475361902755840 |
---|---|
author | Semá Baltazar, Cynthia Horth, Roberta Boothe, Makini Sathane, Isabel Young, Peter Chitsondzo Langa, Denise Condula, Manuel Ricardo, Helena Dengo Baloi, Liliana Cummings, Beverley Schaad, Nicolas Gouveia, Lídia Teodoro, Eugénia Raymond, Henry F. |
author_facet | Semá Baltazar, Cynthia Horth, Roberta Boothe, Makini Sathane, Isabel Young, Peter Chitsondzo Langa, Denise Condula, Manuel Ricardo, Helena Dengo Baloi, Liliana Cummings, Beverley Schaad, Nicolas Gouveia, Lídia Teodoro, Eugénia Raymond, Henry F. |
author_sort | Semá Baltazar, Cynthia |
collection | PubMed |
description | BACKGROUND: Few countries in sub-Saharan Africa know the magnitude of their HIV epidemic among people who inject drugs (PWID). This was the first study in Mozambique to measure prevalence of HIV, HBV, and HCV, and to assess demographic characteristics and risk behaviors in this key population. METHODS: We used respondent-driven sampling (RDS) to conduct a cross-sectional behavioral surveillance survey of PWID in two cities of Mozambique lasting six months. Participants were persons who had ever injected drugs without a prescription. Participants completed a behavioral questionnaire and provided blood specimens for HIV, hepatitis B surface antigen (HBsAg) and hepatitis C virus antibody (anti-HCV) testing. We performed RDS-adjusted analysis in R 3.2 using RDSAT 7.1 weights. RESULTS: We enrolled 353 PWID in Maputo and 139 in Nampula/Nacala; approximately 95% of participants were men. Disease prevalence in Maputo and Nampula/Nacala, respectively, was 50.1 and 19.9% for HIV, 32.1 and 36.4% for HBsAg positivity, and 44.6 and 7.0% for anti-HCV positivity. Additionally, 8% (Maputo) and 28.6% (Nampula/Nacala) of PWID reported having a genital sore or ulcer in the 12 months preceding the survey. Among PWID who injected drugs in the last month, 50.3% (Maputo) and 49.6% (Nampula/Nacala) shared a needle at least once that month. Condomless sex in the last 12 months was reported by 52.4% of PWID in Maputo and 29.1% in Nampula/Nacala. Among PWID, 31.6% (Maputo) and 41.0% (Nampula/Nacala) had never tested for HIV. In multivariable analysis, PWID who used heroin had 4.3 (Maputo; 95% confidence interval [CI]: 1.2, 18.2) and 2.3 (Nampula/Nacala; 95% CI: 1.2, 4.9) greater odds of having HIV. CONCLUSION: Unsafe sexual behaviors and injection practices are frequent among PWID in Mozambique, and likely contribute to the disproportionate burden of disease we found. Intensified efforts in prevention, care, and treatment specific for PWID have the potential to limit disease transmission. |
format | Online Article Text |
id | pubmed-6889180 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-68891802019-12-11 High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique Semá Baltazar, Cynthia Horth, Roberta Boothe, Makini Sathane, Isabel Young, Peter Chitsondzo Langa, Denise Condula, Manuel Ricardo, Helena Dengo Baloi, Liliana Cummings, Beverley Schaad, Nicolas Gouveia, Lídia Teodoro, Eugénia Raymond, Henry F. BMC Infect Dis Research Article BACKGROUND: Few countries in sub-Saharan Africa know the magnitude of their HIV epidemic among people who inject drugs (PWID). This was the first study in Mozambique to measure prevalence of HIV, HBV, and HCV, and to assess demographic characteristics and risk behaviors in this key population. METHODS: We used respondent-driven sampling (RDS) to conduct a cross-sectional behavioral surveillance survey of PWID in two cities of Mozambique lasting six months. Participants were persons who had ever injected drugs without a prescription. Participants completed a behavioral questionnaire and provided blood specimens for HIV, hepatitis B surface antigen (HBsAg) and hepatitis C virus antibody (anti-HCV) testing. We performed RDS-adjusted analysis in R 3.2 using RDSAT 7.1 weights. RESULTS: We enrolled 353 PWID in Maputo and 139 in Nampula/Nacala; approximately 95% of participants were men. Disease prevalence in Maputo and Nampula/Nacala, respectively, was 50.1 and 19.9% for HIV, 32.1 and 36.4% for HBsAg positivity, and 44.6 and 7.0% for anti-HCV positivity. Additionally, 8% (Maputo) and 28.6% (Nampula/Nacala) of PWID reported having a genital sore or ulcer in the 12 months preceding the survey. Among PWID who injected drugs in the last month, 50.3% (Maputo) and 49.6% (Nampula/Nacala) shared a needle at least once that month. Condomless sex in the last 12 months was reported by 52.4% of PWID in Maputo and 29.1% in Nampula/Nacala. Among PWID, 31.6% (Maputo) and 41.0% (Nampula/Nacala) had never tested for HIV. In multivariable analysis, PWID who used heroin had 4.3 (Maputo; 95% confidence interval [CI]: 1.2, 18.2) and 2.3 (Nampula/Nacala; 95% CI: 1.2, 4.9) greater odds of having HIV. CONCLUSION: Unsafe sexual behaviors and injection practices are frequent among PWID in Mozambique, and likely contribute to the disproportionate burden of disease we found. Intensified efforts in prevention, care, and treatment specific for PWID have the potential to limit disease transmission. BioMed Central 2019-12-02 /pmc/articles/PMC6889180/ /pubmed/31791273 http://dx.doi.org/10.1186/s12879-019-4655-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Semá Baltazar, Cynthia Horth, Roberta Boothe, Makini Sathane, Isabel Young, Peter Chitsondzo Langa, Denise Condula, Manuel Ricardo, Helena Dengo Baloi, Liliana Cummings, Beverley Schaad, Nicolas Gouveia, Lídia Teodoro, Eugénia Raymond, Henry F. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique |
title | High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique |
title_full | High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique |
title_fullStr | High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique |
title_full_unstemmed | High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique |
title_short | High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique |
title_sort | high prevalence of hiv, hbsag and anti-hcv positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in mozambique |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889180/ https://www.ncbi.nlm.nih.gov/pubmed/31791273 http://dx.doi.org/10.1186/s12879-019-4655-2 |
work_keys_str_mv | AT semabaltazarcynthia highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique AT horthroberta highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique AT boothemakini highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique AT sathaneisabel highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique AT youngpeter highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique AT chitsondzolangadenise highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique AT condulamanuel highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique AT ricardohelena highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique AT dengobaloililiana highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique AT cummingsbeverley highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique AT schaadnicolas highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique AT gouveialidia highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique AT teodoroeugenia highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique AT raymondhenryf highprevalenceofhivhbsagandantihcvpositivityamongpeoplewhoinjecteddrugsresultsofthefirstbiobehavioralsurveyusingrespondentdrivensamplingintwourbanareasinmozambique |